Maximal and submaximal treadmill tests in a young adult with fragile-X syndrome

Annales de Readaptation et de Medecine Physique

Volumn 51, Issue 8, 2008, Pages 683-691

  Bricout, V A ^a,c   Flore, P ^a,c   Eberhard, Y ^c   Faure, P ^b   Guinot, M ^a   Favre Juvin, A ^a  

^a Clinique physiologie   (France)

^b INSERM   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Fragile X; Hormonal and metabolic responses; Physical test

Indexed keywords

ADRENALIN; CATECHOLAMINE; HYDROCORTISONE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CASE REPORT; CATECHOLAMINE RELEASE; FRAGILE X SYNDROME; HUMAN; HYDROCORTISONE RELEASE; MALE; NORADRENALIN BLOOD LEVEL; TREADMILL EXERCISE;

EID: 55549110759     PISSN: 01686054     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annrmp.2008.06.001     Document Type: Article

References (26)

1. Bregman J.D., Leckman J.F., and Ort S.I. Thyroid function in fragile-X syndrome males. Yale J Biol Med 63 4 (1990) 293-299
2. Bricout V.A., Guinot M., Faure P., Flore P., Eberhard Y., Garnier P., et al. Are hormonal responses to exercise in young men with Down's Syndrome related to reduced endurance performance?. J Neuroendocrinol (2008)
3. Butler M.G., Brunschwig A., Miller L.K., and Hagerman R.J. Standards for selected anthropometric measurements in males with the fragile X syndrome. Pediatrics 89 6 Pt 1 (1992) 1059-1062
4. Butler M.G., and Najjar J.L. Do some patients with fragile X syndrome have precocious puberty?. Am J Med Genet 31 4 (1988) 779-781
5. Christensen N.J., and Galbo H. Sympathetic nervous activity during exercise. Annu Rev Physiol 45 (1983) 139-153
6. Cohen I.L., Fisch G.S., Sudhalter V., Wolf-Schein E.G., Hanson D., Hagerman R., et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard 92 5 (1988) 436-446
7. Fu Y.H., Kuhl D.P., Pizzuti A., Pieretti M., Sutcliffe J.S., Richards S., et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67 6 (1991) 1047-1058
8. Gothelf D., Furfaro J.A., Hoeft F., Eckert M.A., Hall S.S., O'Hara R., et al. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP). Ann Neurol 63 1 (2008) 40-51
9. Gould E.L., Loesch D.Z., Martin M.J., Hagerman R.J., Armstrong S.M., and Huggins R.M. Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J Med Genet 95 4 (2000) 307-315
10. Hagerman R.J., Amiri K., and Cronister A. Fragile X checklist. Am J Med Genet 38 2-3 (1991) 283-287
11. Hagerman R.J., Staley L.W., O'Conner R., Lugenbeel K., Nelson D., McLean S.D., et al. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97 1 (1996) 122-126
12. Hagerman R.J., Van Housen K., Smith A.C., and McGavran L. Consideration of connective tissue dysfunction in the fragile X syndrome. Am J Med Genet 17 1 (1984) 111-121
13. Hessl D., Dyer-Friedman J., Glaser B., Wisbeck J., Barajas R.G., Taylor A., et al. The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome. Pediatrics 108 5 (2001) E88
14. Hessl D., Glaser B., Dyer-Friedman J., Blasey C., Hastie T., Gunnar M., et al. Cortisol and behavior in fragile X syndrome. Psychoneuroendocrinology 27 7 (2002) 855-872
15. Hessl D., Rivera S.M., and Reiss A.L. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev 10 1 (2004) 17-24
16. Kjaer M., Mikines K.J., Christensen N.J., Tronier B., Vinten J., Sonne B., et al. Glucose turnover and hormonal changes during insulin-induced hypoglycemia in trained humans. J Appl Physiol 57 1 (1984) 21-27
17. Lauterborn J.C. Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice. Brain Res Mol Brain Res 131 1-2 (2004) 101-109
18. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., et al. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev 23 1-2 (1997) 79-133
19. Miller L.J., McIntosh D.N., McGrath J., Shyu V., Lampe M., Taylor A.K., et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 83 4 (1999) 268-279
20. Miyashiro K.Y., Beckel-Mitchener A., Purk T.P., Becker K.G., Barret T., Liu L., et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37 3 (2003) 417-431
21. Partington M.W. The fragile X syndrome II: preliminary data on growth and development in males. Am J Med Genet 17 1 (1984) 175-194
22. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 10 (2000) 925-935
23. Snow K., Doud L.K., Hagerman R., Pergolizzi R.G., Erster S.H., and Thibodeau S.N. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53 6 (1993) 1217-1228
24. Watt M.J., Howlett K.F., Febbraio M.A., Spriet L.L., and Hargreaves M. Adrenaline increases skeletal muscle glycogenolysis, pyruvate dehydrogenase activation and carbohydrate oxidation during moderate exercise in humans. J Physiol 534 Pt 1 (2001) 269-278
25. Wisbeck J.M., Huffman L.C., Freund L., Gunnar M.R., Davis E.P., and Reiss A.L. Cortisol and social stressors in children with fragile X: a pilot study. J Dev Behav Pediatr 21 4 (2000) 278-282
26. Zalfa F., Achsel T., and Bagni C. mRNPs, polysomes or granules: FMRP in neuronal protein synthesis. Curr Opin Neurobiol 16 3 (2006) 265-269